Brazil vs Sao Tome and Principe: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Brazil
86.0%
in 2024
Sao Tome and Principe
86.0%
in 2024
Brazil rank
83rd
Sao Tome and Principe rank
83rd
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Brazil
- Sao Tome and Principe
How they compare
Brazil currently reports 86.0% against 86.0% in Sao Tome and Principe, a difference of 0.0%.
Across all 12 years both countries report, Sao Tome and Principe has been ahead every year.
Brazil ranks 83rd and Sao Tome and Principe ranks 83rd of 146 countries.
Sao Tome and Principe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Sao Tome and Principe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 86.4% | 95.6% | 9.1% | Sao Tome and Principe |
| 2020s | 76.0% | 91.4% | 15.4% | Sao Tome and Principe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Brazil or Sao Tome and Principe?
- Brazil, at 86.0% against 86.0% in Sao Tome and Principe as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Brazil and Sao Tome and Principe?
- 0.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Sao Tome and Principe?
- 12 years are reported by both, from 2013 to 2024.
- How do Brazil and Sao Tome and Principe rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Brazil ranks 83rd and Sao Tome and Principe ranks 83rd of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.